Methylation and gene silencing of the ras-related GTPase gene in lung and breast cancers

Annals of Surgical Oncology

Volumn 14, Issue 4, 2007, Pages 1397-1404

  Suzuki, Makoto ^a,b   Shigematsu, Hisayuki ^b   Shames, David S ^b   Sunaga, Noriaki ^a   Takahashi, Takao ^b   Shivapurkar, Narayan ^b   Iizasa, Toshihiko ^a   Minna, John D ^b   Fujisawa, Takehiko ^a   Gazdar, Adi F ^b  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Breast cancer; Lung cancer; Methylation; RRAD

Indexed keywords

BISULFITE; GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; PROTEIN RRAD; RAS PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BRONCHUS MUCOSA; CANCER CELL CULTURE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; EPIGENETICS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SMOKING;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 34047237085     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9089-6     Document Type: Article

References (25)

1. Reynet C, Kahn CR. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science 1993;262:1441-4.
2. Zhu J, Reynet C, Caldwell JS, et al. Characterization of Rad, a new member of Ras/GTPase superfamily, and its regulation by a unique GTPase-activating protein (GAP)-like activity. J Biol Chem 1995; 270:4805-12.
3. Zhu J, Tseng YH, Kantor JD, et al. Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. Proc Natl Acad Sci U S A 1999;96:14911-8.
4. Moyers JS, Bilan PJ, Reynet C, et al. Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells. J Biol Chem 1996; 271:23111-6.
5. Billiard J, Moran RA, Whitley MZ, et al. Transcriptional profiling of human osteoblast differentiation. J Cell Biochem 2003; 89:389-400.
6. Tseng YH, Vicent D, Zhu J, et al. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. Cancer Res 2001; 61:2071-9.
7. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28.
8. Zochbauer-Muller S, Minna JD, Gazdar AF. Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist 2002; 7:451-7.
9. Suzuki M, Shigematsu H, Shames DS, et al. DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. Br J Cancer 2005; 93:1029-37.
10. Suzuki M, Toyooka S, Shivapurkar N, et al. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 2005; 24:1302-8.
11. Suzuki M, Hao C, Takahashi T, et al. Aberrant methylation of SPARC in human lung cancers. Br J Cancer 2005; 92:942-8.
12. Suzuki M, Chen H, Shigematsu H, et al. Aberrant methylation: common in thymic carcinomas, rare in thymomas. Oncol Rep 2005; 14:1621-4.
13. Suzuki M, Sunaga N, Shames DS, et al. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 2004; 64:3137-43.
14. Suzuki M, Shigematsu H, Takahashi T, et al. Aberrant methylation of Reprimo in lung cancer. Lung Cancer 2005; 47:309-14.
15. Chen H, Suzuki M, Nakamura Y, et al. Aberrant methylation of FBN2 in human non-small cell lung cancer. Lung Cancer 2005; 50:43-9.
16. Kulaeva OI, Draghici S, Tang L, et al. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 2003; 22:4118-27.
17. Sato S, Nakamura Y, Tsuchiya E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 1994; 54:5652-5.
18. Girard L, Zochbauer-Muller S, Virmani AK, et al. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000; 60:4894-906.
19. Callen DF, Crawford J, Derwas C, et al. Defining regions of loss of heterozygosity of 16q in breast cancer cell lines. Cancer Genet Cytogenet 2002; 133:76-82.
20. Phelps RM, Johnson BE, Ihde DC, et al. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem 1996; 24(Suppl):32-91.
21. Gazdar AF, Kurvari V, Virmani A, et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 1998; 78:766-74.
22. Herrmann BG, Frischauf AM. Isolation of genomic DNA. Methods Enzymol 1987; 152:180-3.
23. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821-6.
24. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261-82.
25. Toyooka S, Maruyama R, Toyooka KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 2003; 103:153-60.